Key Points
MLMDV.PA stock holds €9.4 flat in pre-market with minimal 75-share volume.
Stock down 21.67% YTD, trading below 50-day and 200-day moving averages.
Meyka AI rates MLMDV.PA with B grade and HOLD, projecting €5.85 yearly downside.
Extreme illiquidity and negative earnings create significant risks for investors.
Medical Devices Venture S.A. (MLMDV.PA) opened flat at €9.4 during pre-market trading on May 2, 2026, on EURONEXT with minimal volume activity. The health technology investment company, headquartered in Igny, France, shows no price movement from the previous close. MLMDV.PA stock has declined 21.67% over the past six months, trading well below its 50-day average of €10.86. With only 75 shares traded and a market cap of €12.3 million, liquidity remains extremely thin. Investors tracking MLMDV.PA stock should monitor upcoming trading sessions for potential volume shifts.
MLMDV.PA Stock Price Performance and Technical Levels
MLMDV.PA stock remains anchored at €9.4, unchanged from Friday’s close. The stock trades significantly below its 50-day moving average of €10.86 and its 200-day average of €11.69, signaling sustained downward pressure.
Year-to-date, MLMDV.PA stock has fallen 21.67%, with the 52-week range spanning €9.4 to €12.7. The stock hit its yearly low at current levels, suggesting potential support formation. Resistance sits near the €10.86 level, while the €12.7 mark represents the 52-week high. Track MLMDV.PA on Meyka for real-time price updates and technical analysis.
Market Sentiment: Trading Activity and Liquidity Concerns
Pre-market volume for MLMDV.PA stock stands at just 75 shares, compared to an average daily volume of only 1 share. This extreme illiquidity creates significant challenges for position entry and exit.
The relative volume ratio of 75.0 indicates today’s activity is substantially above the typical baseline, yet absolute numbers remain negligible. Such thin trading conditions mean large orders could face substantial slippage. Investors should exercise caution with market orders and consider limit orders when trading MLMDV.PA stock. The lack of institutional interest suggests retail participation drives most activity.
Financial Metrics and Valuation Analysis
MLMDV.PA stock trades at a price-to-book ratio of 7.72, indicating premium valuation relative to tangible assets. The negative earnings per share of -€0.2 reflects ongoing losses, with a negative PE ratio of -47.0 due to unprofitability.
Key metrics reveal operational challenges: negative net profit margin of -100.6%, negative return on equity of -57.8%, and negative free cash flow per share of -€0.42. The current ratio of 2.05 shows adequate short-term liquidity, while cash per share stands at €1.42. These metrics suggest MLMDV.PA stock remains in a development phase with significant cash burn.
Meyka AI Grade and Forward Outlook
Meyka AI rates MLMDV.PA with a grade of B and a HOLD suggestion, with a total score of 60.18. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The assessment reflects mixed fundamentals balanced against the company’s position in health technologies.
Meyka AI’s forecast model projects MLMDV.PA stock at €5.85 yearly, representing 37.8% downside from current levels. Three-year forecasts suggest €2.78, indicating continued pressure. These grades and forecasts are not guaranteed, and we are not financial advisors. Investors should conduct thorough research before making decisions.
Final Thoughts
MLMDV.PA stock remains flat at €9.4 during pre-market trading, reflecting minimal investor activity and extreme illiquidity. The health technology investment company faces significant headwinds, including negative earnings, negative cash flow, and a 21.67% decline over six months. Meyka AI’s B grade with HOLD recommendation suggests cautious positioning, while forward forecasts indicate potential further downside. The thin trading volume of 75 shares highlights liquidity risks for investors. Those considering MLMDV.PA stock should prioritize limit orders and conduct comprehensive due diligence on the company’s investment portfolio and cash runway before committing capital.
FAQs
MLMDV.PA stock suffers from extreme illiquidity with only 1 average daily share traded. The small market cap of €12.3 million and limited institutional interest create minimal trading activity. This makes position entry and exit challenging for investors.
The negative PE ratio of -47.0 indicates MLMDV.PA stock is unprofitable, with negative earnings per share of -€0.2. Traditional valuation metrics become unreliable for loss-making companies. Investors must focus on cash position and burn rate instead.
Meyka AI rates MLMDV.PA stock as HOLD with a B grade. Forward forecasts project €5.85 yearly, suggesting 37.8% downside. The company faces negative cash flow and ongoing losses. Conduct thorough research before investing.
MLMDV.PA stock has a market cap of €12.3 million with 1.31 million shares outstanding. This small capitalization contributes to extreme illiquidity and limited analyst coverage. The company remains a micro-cap investment.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)